182 related articles for article (PubMed ID: 18443572)
1. Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients.
Henschkowski J; Stuck AE; Frey BM; Gillmann G; Dick B; Frey FJ; Mohaupt MG
Am J Hypertens; 2008 Jun; 21(6):644-9. PubMed ID: 18443572
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
Campino C; Martinez-Aguayo A; Baudrand R; Carvajal CA; Aglony M; Garcia H; Padilla O; Kalergis AM; Fardella CE
Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
[TBL] [Abstract][Full Text] [Related]
3. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A
J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322
[TBL] [Abstract][Full Text] [Related]
4. 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.
Glorioso N; Filigheddu F; Parpaglia PP; Soro A; Troffa C; Argiolas G; Mulatero P
Eur Heart J; 2005 Mar; 26(5):498-504. PubMed ID: 15618035
[TBL] [Abstract][Full Text] [Related]
5. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
[TBL] [Abstract][Full Text] [Related]
6. 11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension.
Campino C; Carvajal CA; Cornejo J; San Martín B; Olivieri O; Guidi G; Faccini G; Pasini F; Sateler J; Baudrand R; Mosso L; Owen GI; Kalergis AM; Padilla O; Fardella CE
Endocrine; 2010 Feb; 37(1):106-14. PubMed ID: 19882252
[TBL] [Abstract][Full Text] [Related]
7. 11β-Hydroxysteroid dehydrogenase type 2 in hypertension: comparison of phenotype and genotype analysis.
Kosicka K; Cymerys M; Majchrzak-Celińska A; Chuchracki M; Główka FK
J Hum Hypertens; 2013 Aug; 27(8):510-5. PubMed ID: 23303402
[TBL] [Abstract][Full Text] [Related]
8. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
[TBL] [Abstract][Full Text] [Related]
9. Cortisol metabolism in depressed patients and healthy controls.
Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
[TBL] [Abstract][Full Text] [Related]
10. 11β-hydroxysteroid dehydrogenase type 2 polymorphisms and activity in a Chilean essential hypertensive and normotensive cohort.
Campino C; Quinteros H; Owen GI; Carvajal CA; Morales M; Olivieri O; Guidi G; Faccini G; Pasini F; Baudrand R; Padilla O; Valdivia C; Thichauer J; Lagos CF; Kalergis AM; Fardella CE
Am J Hypertens; 2012 May; 25(5):597-603. PubMed ID: 22278213
[TBL] [Abstract][Full Text] [Related]
11. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
[TBL] [Abstract][Full Text] [Related]
13. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
[TBL] [Abstract][Full Text] [Related]
14. Extracellular ATP determines 11beta-hydroxysteroid dehydrogenase type 2 activity via purinergic receptors.
Kadereit B; Fustier P; Shojaati K; Frey BM; Frey FJ; Mohaupt MG
J Am Soc Nephrol; 2005 Dec; 16(12):3507-16. PubMed ID: 16251242
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone effective hypertension in the elderly due to 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) impairment: contributory role of determining serum cortisol/cortisone ratio as a marker of 11beta-HSD2 activity.
Inada M; Iwasaki K; Imai C; Hashimoto S
Intern Med; 2008; 47(24):2157-64. PubMed ID: 19075542
[TBL] [Abstract][Full Text] [Related]
16. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver.
Quinkler M; Jussli J; Bähr V; Pfeiffer AF; Lepenies J; Diederich S
Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719
[TBL] [Abstract][Full Text] [Related]
17. Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis.
N'Gankam V; Uehlinger D; Dick B; Frey BM; Frey FJ
Kidney Int; 2002 May; 61(5):1859-66. PubMed ID: 11967038
[TBL] [Abstract][Full Text] [Related]
18. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
Mosso L; Carvajal C; Campino C; Rojas A; González A; Barraza A; Montero J; Fardella C
Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
[TBL] [Abstract][Full Text] [Related]
19. HPLC method for determination of fluorescence derivatives of cortisol, cortisone and their tetrahydro- and allo-tetrahydro-metabolites in biological fluids.
Główka FK; Kosicka K; Karaźniewicz-Łada M
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):283-9. PubMed ID: 20018571
[TBL] [Abstract][Full Text] [Related]
20. Pediatric renal allograft transplantation does not normalize the increased cortisol/cortisone ratios of chronic renal failure.
Schroth M; Plank C; Rauh M; Dörr HG; Rascher W; Dötsch J
Eur J Endocrinol; 2006 Apr; 154(4):555-61. PubMed ID: 16556718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
